http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102456432-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| filingDate | 2017-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102456432-B1 |
| titleOfInvention | Medicinal salts of heterocyclic imidazole compounds for antitumor |
| abstract | The present invention relates to the field of drug synthesis, and specifically, the heterocyclic imidazole compound (I) for antitumor, that is, 4-(3-(4-(hydro-imidazo[4,5-b]pyridine-5) It relates to a medicated salt of -yl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazine-1(dihydro)-ketone, a method for preparing the same, a drug combination and use in the manufacture of an antitumor drug . The medicinal salt of the compound (I) of the present invention can be used for the manufacture of a drug for treating or preventing a disease that can be improved by inhibiting PARP activity. |
| priorityDate | 2016-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.